E-Learning

European markets were in the red on Friday morning after China vowed to retaliate as necessary to Donald Trump's extra 10% tariff hike.View on euronews

The answer depends on your goals, risk tolerance, current asset allocation.

Over the past six months, Revvity’s shares (currently trading at $111) have posted a disappointing 8.5% loss, well below the S&P 500’s 5.1% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Over the past six months, BD’s shares (currently trading at $224.85) have posted a disappointing 5.9% loss, well below the S&P 500’s 5.1% gain. This might have investors contemplating their next move.

RH’s 23.3% return over the past six months has outpaced the S&P 500 by 18.2%, and its stock price has climbed to $329.50 per share. This run-up might have investors contemplating their next move.

AbbVie trades at $205.51 per share and has stayed right on track with the overall market, gaining 5.2% over the last six months. At the same time, the S&P 500 has returned 5.1%.

Schneider has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $26.09. The stock also fell short of the S&P 500’s 5.1% gain during that period.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how water infrastructure stocks fared in Q4, starting with Xylem (NYSE:XYL).

Shareholders of Caleres would probably like to forget the past six months even happened. The stock dropped 59.8% and now trades at $16.98. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

Over the last six months, Graphic Packaging Holding’s shares have sunk to $26.27, producing a disappointing 10.5% loss - a stark contrast to the S&P 500’s 5.1% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.